Entasis Therapeutics Holdings Inc. (ETTX) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16
	10-K	10-K	10-K	10-K	10-K	S-1/A
Revenues	0.0	0.0	7.0	5.0	0.0	15.8
Revenue growth		-100.0%	40.0%		-100.0%
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	19.1
Gross profit	0.0	0.0	7.0	5.0	0.0	-3.3
Gross margin			100.0%	100.0%		-21.1%
Selling, general and administrative [+]	15.2	13.2	13.8	10.2	5.6	3.3
General and administrative	15.2	13.2	13.8	10.2	5.6	3.3
Research and development	37.1	41.0	40.2	33.0	25.7
Other operating expenses						12.5
EBITDA [+]	-52.2	-54.1	-46.8	-38.0	-31.2	-18.9
EBITDA growth	-3.5%	15.6%	23.0%	22.1%	64.6%
EBITDA margin			-668.5%	-760.9%		-120.0%
Depreciation and amortization	0.1	0.1	0.1	0.2	0.2	0.2
EBIT [+]	-52.3	-54.2	-46.9	-38.2	-31.3	-19.1
EBIT growth	-3.5%	15.5%	22.8%	21.9%	64.1%
EBIT margin			-670.5%	-764.1%		-121.1%
Interest income	0.0	0.2	1.5	0.4	0.0	0.0
Interest income	0.0	0.2	1.5	0.4	0.0	0.0
Other income (expense), net	5.2	3.6	2.3	5.3	1.4
Pre-tax income	-47.1	-50.5	-43.2	-32.5	-29.9	-19.1
Income taxes	0.0	0.0	0.7	0.5	0.0	0.0
Tax rate	0.0%	0.0%			0.0%	0.0%
Net income	-47.1	-50.5	-43.9	-42.1	-29.9	-19.1
Net margin			-626.4%	-841.9%		-121.0%

Basic EPS [+]	($1.09)	($2.10)	($3.33)	($12.31)	($13,795.76)
Growth	-48.2%	-37.0%	-72.9%	-99.9%
Diluted EPS [+]	($1.09)	($2.10)	($3.33)	($12.31)	($13,795.76)
Growth	-48.2%	-37.0%	-72.9%	-99.9%


Shares outstanding (basic) [+]	43.3	24.1	13.2	3.4	0.0
Growth	80.1%	82.8%	284.8%	157563.4%
Shares outstanding (diluted) [+]	43.3	24.1	13.2	3.4	0.0
Growth	80.1%	82.8%	284.8%	157563.4%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.